Global

Jul 19, 2018
With China predicted to account for 48% of the global diabetes population by 2045, Jin Zhang looks at how the country's domestic pharma companies are faring in this treatment area.
Jul 18, 2018
Research-based companies in Europe look as though they have lost one battle on preserving incentives for innovation – but the bigger war is only now getting underway, writes Reflector.
Jul 09, 2018
Raman Sehgal talks to three industry leaders for their insights on the challenges faced across the life science sector and how the EMA needs to respond.
Jul 09, 2018
Global pharma companies and Japan can create a win-win situation through a new pricing mechanism, writes Nobuko Kobayashi.
Jul 07, 2018
Filip Conic outlines the market-access approaches and commercial strategies to unlock the growth potential in the Southeastern and Eastern European region.
Jun 21, 2018
China's nurse educator program aims to improve quality of care and make life simpler for physicians handling high patient load. Sebastian Bather reports.
Jun 19, 2018
On May 1, China eliminated the tariff on 28 categories of imported drugs. Jin Zhang looks at the implications for foreign and domestic pharma companies.
Jun 19, 2018
Figuring out the workings of the EU in topics related to health can be akin to deciphering Egyptian hieroglyphs, making it challenging for companies to plan ahead, writes Reflector.
Jun 18, 2018
Pharmaceutical Executive
Weighing the crossover effect of US’s new pricing blueprint. 
Jun 01, 2018
The PD-1/PD-L1 market in China is heating up and companies there have made a series of advances, writes Jin Zhang.
native1_300x100
lorem ipsum